chr16-24273887-A-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006539.4(CACNG3):c.211+16922A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.421 in 151,958 control chromosomes in the GnomAD database, including 13,813 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.42   (  13813   hom.,  cov: 31) 
Consequence
 CACNG3
NM_006539.4 intron
NM_006539.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.0470  
Publications
5 publications found 
Genes affected
 CACNG3  (HGNC:1407):  (calcium voltage-gated channel auxiliary subunit gamma 3) The protein encoded by this gene is a type I transmembrane AMPA receptor regulatory protein (TARP). TARPs regulate both trafficking and channel gating of the AMPA receptors. This gene is part of a functionally diverse eight-member protein subfamily of the PMP-22/EMP/MP20 family. This gene is a susceptibility locus for childhood absence epilepsy. [provided by RefSeq, Dec 2010] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.549  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.421  AC: 63987AN: 151840Hom.:  13798  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
63987
AN: 
151840
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.421  AC: 64037AN: 151958Hom.:  13813  Cov.: 31 AF XY:  0.420  AC XY: 31227AN XY: 74264 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
64037
AN: 
151958
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
31227
AN XY: 
74264
show subpopulations 
African (AFR) 
 AF: 
AC: 
13994
AN: 
41432
American (AMR) 
 AF: 
AC: 
6714
AN: 
15262
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1571
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
2923
AN: 
5164
South Asian (SAS) 
 AF: 
AC: 
1875
AN: 
4818
European-Finnish (FIN) 
 AF: 
AC: 
4524
AN: 
10558
Middle Eastern (MID) 
 AF: 
AC: 
100
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
31147
AN: 
67940
Other (OTH) 
 AF: 
AC: 
890
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 1864 
 3728 
 5593 
 7457 
 9321 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 602 
 1204 
 1806 
 2408 
 3010 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1518
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.